Global Pharmaceutical Stability & Storage Service 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR032500433

Publication Date:

March 3, 2025

Pages:

105

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global Pharmaceutical Stability & Storage Service market size was valued at US$ 61.9 million in 2024 and is forecast to a readjusted size of USD 81.8 million by 2031 with a CAGR of 4.1% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Pharmaceutical Stability & Storage Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Stability & Storage Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Stability & Storage Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Stability & Storage Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Stability & Storage Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Stability & Storage Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Stability & Storage Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Almac, Auriga Research, Boston Analytical, Catalent, Element, Eurofins Scientific, Intertek, Masy BioServices, Precision Stability Storage, Q1 Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Pharmaceutical Stability & Storage Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Pharmaceutical Stability Service
Pharmaceutical Storage Service
麻豆原创 segment by Application
Macromolecular Pharmaceuticals
Small Molecule Pharmaceuticals
Bio-pharmacy
Other
麻豆原创 segment by players, this report covers
Almac
Auriga Research
Boston Analytical
Catalent
Element
Eurofins Scientific
Intertek
Masy BioServices
Precision Stability Storage
Q1 Scientific
SGS
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical Stability & Storage Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical Stability & Storage Service, with revenue, gross margin, and global market share of Pharmaceutical Stability & Storage Service from 2020 to 2025.
Chapter 3, the Pharmaceutical Stability & Storage Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical Stability & Storage Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Stability & Storage Service.
Chapter 13, to describe Pharmaceutical Stability & Storage Service research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical Stability & Storage Service by Type
1.3.1 Overview: Global Pharmaceutical Stability & Storage Service 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Pharmaceutical Stability & Storage Service Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Pharmaceutical Stability Service
1.3.4 Pharmaceutical Storage Service
1.4 Global Pharmaceutical Stability & Storage Service 麻豆原创 by Application
1.4.1 Overview: Global Pharmaceutical Stability & Storage Service 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Macromolecular Pharmaceuticals
1.4.3 Small Molecule Pharmaceuticals
1.4.4 Bio-pharmacy
1.4.5 Other
1.5 Global Pharmaceutical Stability & Storage Service 麻豆原创 Size & Forecast
1.6 Global Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast by Region
1.6.1 Global Pharmaceutical Stability & Storage Service 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Pharmaceutical Stability & Storage Service 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Pharmaceutical Stability & Storage Service 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Pharmaceutical Stability & Storage Service 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Pharmaceutical Stability & Storage Service 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Pharmaceutical Stability & Storage Service 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Pharmaceutical Stability & Storage Service 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Almac
2.1.1 Almac Details
2.1.2 Almac Major Business
2.1.3 Almac Pharmaceutical Stability & Storage Service Product and Solutions
2.1.4 Almac Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Almac Recent Developments and Future Plans
2.2 Auriga Research
2.2.1 Auriga Research Details
2.2.2 Auriga Research Major Business
2.2.3 Auriga Research Pharmaceutical Stability & Storage Service Product and Solutions
2.2.4 Auriga Research Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Auriga Research Recent Developments and Future Plans
2.3 Boston Analytical
2.3.1 Boston Analytical Details
2.3.2 Boston Analytical Major Business
2.3.3 Boston Analytical Pharmaceutical Stability & Storage Service Product and Solutions
2.3.4 Boston Analytical Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Boston Analytical Recent Developments and Future Plans
2.4 Catalent
2.4.1 Catalent Details
2.4.2 Catalent Major Business
2.4.3 Catalent Pharmaceutical Stability & Storage Service Product and Solutions
2.4.4 Catalent Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Catalent Recent Developments and Future Plans
2.5 Element
2.5.1 Element Details
2.5.2 Element Major Business
2.5.3 Element Pharmaceutical Stability & Storage Service Product and Solutions
2.5.4 Element Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Element Recent Developments and Future Plans
2.6 Eurofins Scientific
2.6.1 Eurofins Scientific Details
2.6.2 Eurofins Scientific Major Business
2.6.3 Eurofins Scientific Pharmaceutical Stability & Storage Service Product and Solutions
2.6.4 Eurofins Scientific Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Eurofins Scientific Recent Developments and Future Plans
2.7 Intertek
2.7.1 Intertek Details
2.7.2 Intertek Major Business
2.7.3 Intertek Pharmaceutical Stability & Storage Service Product and Solutions
2.7.4 Intertek Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Intertek Recent Developments and Future Plans
2.8 Masy BioServices
2.8.1 Masy BioServices Details
2.8.2 Masy BioServices Major Business
2.8.3 Masy BioServices Pharmaceutical Stability & Storage Service Product and Solutions
2.8.4 Masy BioServices Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Masy BioServices Recent Developments and Future Plans
2.9 Precision Stability Storage
2.9.1 Precision Stability Storage Details
2.9.2 Precision Stability Storage Major Business
2.9.3 Precision Stability Storage Pharmaceutical Stability & Storage Service Product and Solutions
2.9.4 Precision Stability Storage Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Precision Stability Storage Recent Developments and Future Plans
2.10 Q1 Scientific
2.10.1 Q1 Scientific Details
2.10.2 Q1 Scientific Major Business
2.10.3 Q1 Scientific Pharmaceutical Stability & Storage Service Product and Solutions
2.10.4 Q1 Scientific Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Q1 Scientific Recent Developments and Future Plans
2.11 SGS
2.11.1 SGS Details
2.11.2 SGS Major Business
2.11.3 SGS Pharmaceutical Stability & Storage Service Product and Solutions
2.11.4 SGS Pharmaceutical Stability & Storage Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 SGS Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Pharmaceutical Stability & Storage Service Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Pharmaceutical Stability & Storage Service by Company Revenue
3.2.2 Top 3 Pharmaceutical Stability & Storage Service Players 麻豆原创 Share in 2024
3.2.3 Top 6 Pharmaceutical Stability & Storage Service Players 麻豆原创 Share in 2024
3.3 Pharmaceutical Stability & Storage Service 麻豆原创: Overall Company Footprint Analysis
3.3.1 Pharmaceutical Stability & Storage Service 麻豆原创: Region Footprint
3.3.2 Pharmaceutical Stability & Storage Service 麻豆原创: Company Product Type Footprint
3.3.3 Pharmaceutical Stability & Storage Service 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Pharmaceutical Stability & Storage Service Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Pharmaceutical Stability & Storage Service 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Pharmaceutical Stability & Storage Service Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Pharmaceutical Stability & Storage Service 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Stability & Storage Service Consumption Value by Type (2020-2031)
6.2 North America Pharmaceutical Stability & Storage Service 麻豆原创 Size by Application (2020-2031)
6.3 North America Pharmaceutical Stability & Storage Service 麻豆原创 Size by Country
6.3.1 North America Pharmaceutical Stability & Storage Service Consumption Value by Country (2020-2031)
6.3.2 United States Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Pharmaceutical Stability & Storage Service Consumption Value by Type (2020-2031)
7.2 Europe Pharmaceutical Stability & Storage Service Consumption Value by Application (2020-2031)
7.3 Europe Pharmaceutical Stability & Storage Service 麻豆原创 Size by Country
7.3.1 Europe Pharmaceutical Stability & Storage Service Consumption Value by Country (2020-2031)
7.3.2 Germany Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Stability & Storage Service Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Pharmaceutical Stability & Storage Service Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Pharmaceutical Stability & Storage Service 麻豆原创 Size by Region
8.3.1 Asia-Pacific Pharmaceutical Stability & Storage Service Consumption Value by Region (2020-2031)
8.3.2 China Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Pharmaceutical Stability & Storage Service Consumption Value by Type (2020-2031)
9.2 South America Pharmaceutical Stability & Storage Service Consumption Value by Application (2020-2031)
9.3 South America Pharmaceutical Stability & Storage Service 麻豆原创 Size by Country
9.3.1 South America Pharmaceutical Stability & Storage Service Consumption Value by Country (2020-2031)
9.3.2 Brazil Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Stability & Storage Service Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Pharmaceutical Stability & Storage Service Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Pharmaceutical Stability & Storage Service 麻豆原创 Size by Country
10.3.1 Middle East & Africa Pharmaceutical Stability & Storage Service Consumption Value by Country (2020-2031)
10.3.2 Turkey Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Pharmaceutical Stability & Storage Service 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Pharmaceutical Stability & Storage Service 麻豆原创 Drivers
11.2 Pharmaceutical Stability & Storage Service 麻豆原创 Restraints
11.3 Pharmaceutical Stability & Storage Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Pharmaceutical Stability & Storage Service Industry Chain
12.2 Pharmaceutical Stability & Storage Service Upstream Analysis
12.3 Pharmaceutical Stability & Storage Service Midstream Analysis
12.4 Pharmaceutical Stability & Storage Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Almac
Auriga Research
Boston Analytical
Catalent
Element
Eurofins Scientific
Intertek
Masy BioServices
Precision Stability Storage
Q1 Scientific
SGS

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.